Michael Dybbs

CIK 1601264 · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

6

Total Filings

25

Lifetime Open-Market Net

$12.50M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NKTX Director $2.86 $0 7 2026-06-11
STRO Director $28.80 $0 10 2026-06-09
KLRS Director $4.33 $0 2 2026-06-04
SGP Director $18.44 $0 1 2026-02-09
Dimension Therapeutics, Inc. (DMTX) Delisted Director 1,097,745 $12.50M 4 2017-11-07
Aravive, Inc. (VSAR) Delisted Director $0 1 2014-03-24

Recent Filings · Page 2 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-12 STRO Grant (A) $0 EDGAR
2023-06-09 NKTX Grant (A) $0 EDGAR
2022-06-10 NKTX Grant (A) $0 EDGAR
2022-06-08 STRO Grant (A) $0 EDGAR
2021-06-15 NKTX Grant (A) $0 EDGAR
2021-06-07 STRO Grant (A) $0 EDGAR
2020-07-13 NKTX Grant (A) $0 EDGAR
2020-06-08 STRO Grant (A) $0 EDGAR
2019-06-19 STRO Grant (A) $0 EDGAR
2018-09-27 STRO Grant (A) $0 EDGAR
Showing 1120 of 25
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.